The use of carbamazepine has been reported to be an effective treatment for severe depression. We have already shown that the antidepressant-like effects of tricyclic antidepressants in the rat forced swim test (FST) are blocked by chronic treatment with adrenocorticotropic hormone (ACTH). In the present study, we examined the effect of the chronic administration of carbamazepine on the FST and the wet-dog shakes induced by 
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The use of carbamazepine has been reported to be an effective treatment for severe depression. We have already shown that the antidepressant-like effects of tricyclic antidepressants in the rat forced swim test (FST) are blocked by chronic treatment with adrenocorticotropic hormone (ACTH). In the present study, we examined the effect of the chronic administration of carbamazepine on the FST and the wet-dog shakes induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT 2A receptor agonist, in ACTH-treated rats. Chronic administration of carbamazepine did not affect the duration of immobility in saline-treated and ACTH-treated rats. The reduction of immobility, induced by chronic administration of imipramine, was blocked by treatment with ACTH. When carbamazepine was administered concurrently with imipramine, we observed a significant decrease in immobility in rats treated with ACTH.
Chronic ACTH treatment increased the number of the wet-dog shakes induced by DOI. This effect of ACTH was significantly increased by the coadministration of carbamazepine and imipramine. These results suggest that the use of carbamazepine together with tricyclic antidepressants had the effect of reducing immobility time in the FST in a tricyclic antidepressant-treatment-resistant depressive model induced by chronic
Introduction
We previously reported that the reduction in the duration of immobility in the forced swim test (FST) caused by the chronic administration of imipramine was inhibited by chronic treatment with adrenocorticotropic hormone (ACTH) (Kitamura et al., 2002a) . Furthermore, chronic coadministration of lithium, an agent which potentiates the actions of antidepressants in patients with depression, including those with treatment-resistant depression (de Montigny et el., 1981) , significantly decreased the duration of immobility, even when given concurrently with ACTH (Kitamura et al., 2002a) . Namely, we reported that ACTH-treated rats served a valuable animal model of tricyclic antidepressant-resistant depressive conditions. The Serotonin (5-HT) receptor subtypes, particularly the 5-HT 2A receptor, have been postulated to play an important role in the pathogenesis of depression (Arango et al., 1990; Arora and Meltzer, 1989; Biegon et al., 1987; Mann et al., 1986; Pandey et al., 2002) . However, psychoendocrinological studies have focused on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis in patients with depression (Carroll et al., 1976) . Information on the mechanism whereby steroid hormones regulate 5-HT function will impact on our understanding of hypercortisolism, a condition typical of affective disorders and treatment-resistant depression (Christie et al., 1986) . We previously reported chronic administration of corticosterone or ACTH increased the number of wet-dog shakes induced by
receptor agonist (Takao et al., 1997 , Kitamura et al., 2002b Kawakami et al., 2005) . Carbamazepine is an antiepileptic and mood-stabilizing drug. It has also been shown to be effective in the treatment of several forms of affective disorders, such as treatment-resistant depression (Calabrese and Delucchi, 1989; Kramlinger and Post, 1989) . Although previous reports have evaluated the effect of carbamazepine in naive animals, few attempts have been made to examine its effects in a model of abnormal activation of the HPA axis.
The purpose of the present study was to examine the effect of carbamazepine and coadministration of imipramine and carbamazepine on the duration of immobility in the FST and 5-HT 2A receptor-mediated behavioral responses induced by DOI in ACTH-treated rats.
Materials and Methods

Animals
Male Wistar rats (Charles River, Japan) weighing 180-230 g, were utilized in this study. The rats were kept under a constant light-dark cycle (lights on, 07.00 -19.00 h), with access to standard laboratory food and tap water in an air-conditioned room (23 ± 1 °C with approximately 60% humidity). All experiments were conducted according to the guidelines for Animal Experimentation at Okayama University Medical School. Every effort was made to minimize the number of animals used and their suffering.
Drugs
The following drugs were used in the study: carbamazepine (Sigma-Aldrich, St. Louis, MO, USA), imipramine hydrochloride (Wako Pure Chemical., Behavioral studies
Measurement of immobility
To measure immobility, rats were individually placed in plastic cylinders (height 37 cm, diameter 15.5 cm) containing 20 cm of water at 25 °C, as described by Porsolt et al. (1978) . Two swim sessions were conducted in the initial 13 min pre-test; a 6 min test followed 24 h later. The total period of immobility during the 6 min testing period was recorded using the TARGET series/7M analysis program (Neuroscience Inc., Tokyo, Japan). (Fig 1B) . The effect of imipramine on the duration of immobility did not change with the coadministration of carbamazepine (Fig. 1B) .
Experiment 2: Effects of chronic administration of imipramine or carbamazepine, and chronic coadministration of imipramine and carbamazepine on the duration of immobility in ACTH-treated rats
The administration of carbamazepine (30 mg/kg, i.p.) for 15 days had no effect on the duration of immobility in the FST in ACTH-treated rats [F(2,15)=1.41, P=0.28] (Fig 2A) . The administration of imipramine (10 mg/kg, i.p.) decreased the duration of immobility (Fig. 1B) , an effect blocked by 14 days of treatment with ACTH (Fig. 2B) (Fig. 2B ).
Experiment 3: Effects of chronic administration of imipramine or carbamazepine, and chronic coadministration of imipramine and carbamazepine on DOI-induced wet-dog shakes in saline-treated rats
The administration of carbamazepine (3 -30 mg/kg, i.p.) for 14 days had no effect on the number of DOI-induced wet-dog shakes [F(3,20) =2.14, P=0.13] (Fig. 3A) . The administration of imipramine (10 mg/kg, i.p.) for 14 days significantly decreased the number of DOI-induced wet-dog shakes [F(2,15)=4.09, P<0.05] (Fig 3B) . The effect of imipramine on the number of DOI-induced wet-dog shakes did not change with the coadministration of carbamazepine (Fig. 3B ).
Experiment 4: Effects of chronic administration of imipramine or carbamazepine, and chronic coadministration of imipramine and carbamazepine on DOI-induced wet-dog shakes in ACTH-treated rats
The number of DOI-induced wet-dog shakes was increased in ACTH-treated rats compared to saline-treated rats [F(2,15)=7.82, P<0.05] (Fig. 4A ). This increase was not affected by the administration of carbamazepine (30 mg/kg, i.p.) for 14 days (Fig. 4A) . However, the number of DOI-induced wet-dog shakes was increased by the coadministration of imipramine (10 mg/kg, i.p.) and carbamazepine (30 mg/kg, i.p.) compared to that in ACTH-treated rats [F(3,28)=27.42, P<0.05] (Fig. 4B ).
Discussion
It is the results of the present study suggest that the chronic coadministration of imipramine and carbamazepine and carbamazepine caused a significant decrease in immobility in the FST in rats treated with ACTH for 14 days. We previously reported that chronic treatment with ACTH inhibited the immobility-decreasing effects of imipramine (Kitamura et al., 2002a) . The current findings confirmed the results of repeated imipramine administration in ACTH-treated rats. Clinically, the use of lithium has been shown to be effective in the treatment of several forms of affective disorders, such as treatment-resistant depression. Using lithium together with tricyclic antidepressants may be a promising way to improve the efficacy of the treatment of resistant depression. It was reported that the inhibition of the immobility-decreasing effect of imipramine was reversed by coadministration of lithium in ACTH-treated rats in the FST (Kitamura et al., 2002a) . Furthermore, we reported that repeated electroconvulsive stimuli decreased the duration of immobility in the FST in chronic ACTH-treated rats (Li et al., 2006) . Electroconvulsive stimuli therapy is considered to be the most effective biological treatment for depression, especially severe intractable depression (Fink et al., 1990) . These findings suggest that the (Kuroda et al., 1992; Kitamura et al., 2002b Kitamura et al., , 2007 .
We recognized that the expression levels of 5-HT 2A receptor mRNA increase with the chronic administration of ACTH (Kitamura et al., in press ).
Furthermore, the enhancing effect on DOI-induced wet-dog shakes is blocked by the coadministration of lithium and imipramine, but not by imipramine alone (Kitamura et al., 2002b) . Thus, it is proposed that the receptor in the rat frontal cortex (Elphick et al., 1990) . The effect of carbamazepine on the 5-HT 2 receptor's function is conflicting. Previously, we reported that repeated electroconvulsive stimuli significantly increased the number of DOI-induced wet-dog shakes in both saline and ACTH-treated rats (Li et al., 2006) , as in the present study. This result,
indicating that the coadministration of imipramine and carbamazepine, and electroconvulsive stimuli action resulted in a disparity between the FST and DOI-induced wet-dog shakes, did not support the hypothesis that the 5-HT 2A
receptor's hyperfunction is involved in the animal model for tricyclic antidepressant-treatment-resistant depressive conditions induced by chronic ACTH treatment (Kitamura et al., 2002b) . Namely, it may mean that inhibition of the 5-HT 2A receptor's function is not a common mechanism behind the effect of antidepressants. It is reported that stimulation of the β-adrenergic receptor with isoproterenol increased cyclic adenosine monophosphate levels and this effect was significantly inhibited by carbamazepine. (Montezinho et al., 2006) . The density of β-adrenergic receptors decreased after chronic treatment of rats with tricyclic antidepressant drugs (Kellar, 1987) . Therefore, further studies are needed to determine whether or not β-adrenergic receptors are involved in the antidepressant-like action of carbamazepine in ACTH-treated rats.
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